- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Do | Heart patient goes home hours after live-streamed valve replacement | ||
| Do | Johnson & Johnson myeloma drug recommended for NHS use | ||
| Mi | Purespring Therapeutics secures £80 million in Series B funding | ||
| Mi | Sanofi launches high-dose flu vaccine in the UK | ||
| Di | Kyowa Kirin announces positive interim data for lymphoma treatment | ||
| Di | Astellas and AviadoBio announce exclusive gene therapy deal | ||
| Mo | FluoGuide submits clinical trial application for head and neck cancer treatment | ||
| Mo | Scottish patients first in UK to access new lung cancer treatment | ||
| 03.10. | IRLAB's new drug shows promise in treating apathy in Parkinson's patients | ||
| 03.10. | ERLEADA shows 23% survival benefit over enzalutamide in prostate cancer study | ||
| 02.10. | Insilico Medicine reports positive results for idiopathic pulmonary fibrosis therapy | ||
| 02.10. | AlzeCure's abstract on ACD856's effects to be presented at Alzheimer's conference | ||
| 01.10. | European Commission approves yuvanci for pulmonary arterial hypertension treatment | ||
| 26.09. | Sheffield A&E to implement life-saving HIV and hepatitis testing | ||
| 26.09. | Oxford drug design secures funding to combat cystic fibrosis lung infections | ||
| 24.09. | Cancer Grand Challenges launches global initiative to take on toughest problems | ||
| 24.09. | AlgoTx completes pivotal phase 2 trial for ground-breaking CIPN treatment | ||
| 19.09. | Oncologica to advance urine-based prostate cancer screening test | ||
| 18.09. | NHS Trust to evaluate AI software for prostate cancer diagnosis | ||
| 18.09. | FlyPharma Europe, Vienna - October 2024 conference | ||
| 17.09. | UKRI's MRC awards £27.4m to University of Dundee research unit | ||
| 16.09. | WHO adds first mpox vaccine to prequalification list | ||
| 13.09. | World Sepsis Day 2024 highlights need for better sepsis treatments | ||
| 13.09. | Nxera and Cancer Research UK to present promising cancer drug trial at ESMO | ||
| 12.09. | HRT linked to reduced psychosis relapse risk in menopausal women |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
